BPA Call 36C24123A0032-36C24125N0488

Award Date 2/1/25
Potential Completion Date 1/31/26
Potential Value $300K
Ultimate Awardee
Veracyte, Inc.
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for PROSTATE TESTING services. The $139,580.92 Blanket Purchase Agreement (BPA) Call contract is with the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 1 (VISN 1), and has a performance period ending on January 31, 2025. The contract was awarded on February 1, 2024 and is a Firm Fixed Price arrangement. Veracyte is a for-profit organization that...
This federal contract award, valued at $184,713.63, was made by the Veterans Integrated Service Network 8 (VISN 8) of the U.S. Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract is for the provision of the Decipher Prostate Cancer Test, a specialized genomic classifier that analyzes tumor gene expression patterns to help clinicians make more informed treatment decisions for prostate cancer patients. The contract is a Blanket Purchase...
This is a firm fixed-price delivery order awarded to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 10. The $84,255.34 contract is for the company's Decipher Prostate Cancer Testing services, which provide genomic analysis to help clinicians make more informed treatment decisions for prostate cancer patients. Veracyte is a for-profit organization that specializes in advanced molecular...
This is a firm fixed price contract awarded by the Veterans Health Administration's Veterans Integrated Service Network 8 (VISN 8) to Veracyte Labs SD Corporation, a division of Veracyte, Inc. The contract, valued at $372,667.85, is for the delivery of the Decipher Prostate Cancer Test, a specialized genomic diagnostic service that analyzes tumor gene expression patterns to help clinicians assess prostate cancer risk and guide treatment decisions. The contract is a Blanket Purchase Agreement...
This federal contract award is for TESTING SERVICES- LAB provided by Veracyte Labs SD Corporation, a subsidiary of Veracyte, Inc. The contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21) and does not have a set-aside designation. The contract, valued at $272,209.56, is a Delivery Order under Veracyte's existing Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services (FSS-621-II). Through this award, Veracyte...
This is a federal contract award to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc., for DECIPHER PROSTATE CANCER TESTING services. The contract, valued at $3,240.59, was awarded by the Veterans Integrated Service Network 17 (VISN 17) of the Department of Veterans Affairs (VA). This is a Firm Fixed Price Blanket Purchase Agreement (BPA) Call contract under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract does...
This federal contract award, valued at $61,571.21, was issued by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II). The contract is for the Decipher Prostate Cancer Testing service, which analyzes tumor gene expression patterns to help clinicians make more informed treatment...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Veracyte, Inc., for the modification of the Decipher Prostate Cancer Testing service. The $64,811.80 contract has an ultimate completion date of November 14, 2026 and is not set aside. Veracyte, a for-profit medical diagnostics company, provides specialized genomic testing services to support precision medicine and personalized...
This is a federal contract award to Veracyte, Inc., a for-profit medical diagnostics company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 16 (VISN 16). The contract is for $405,018.00 and involves the provision of genomic testing services, specifically Veracyte's proprietary genomic testing products and services. This is a firm fixed-price purchase order contract with a period of performance ending on May 31, 2029. The contract is not set aside and appears to...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract, valued at $194,435.40, is a Blanket Purchase Agreement (BPA) call order issued under the VA's Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) contract vehicle. The contract is for Veracyte Labs to provide its proprietary Decipher Prostate Cancer Test, a genomic classifier that...

This is a federal contract award issued by the Veterans Integrated Service Network 1 (VISN 1), which is part of the U.S. Department of Veterans Affairs (VA), to Veracyte Labs SD Corporation, a division of Decipher Biosciences, Inc. The contract is for $300,000.00 and involves the provision of prostate cancer genomic testing and analysis services through a Blanket Purchase Agreement (BPA) call under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) contract. The contract has a period of performance through January 31, 2026.

Veracyte Labs SD Corporation is a specialized genomic testing company that provides advanced molecular diagnostic services focused on prostate cancer. The company's proprietary tests analyze tumor gene expression patterns to aid clinicians in making more informed treatment decisions. This contract award enables VISN 1 healthcare facilities to efficiently access Veracyte's testing capabilities to support personalized cancer care for veterans. The contract is a non-set-aside award, reflecting the specialized nature of the genomic testing services provided.

Generated 1/31/25, 9:13 AM